Expression Table for this CRE
| SRX4504744 | human NET-CAGE MCF-7, response to HRG, 360 min, biol_rep2 | 256.2 |
| SRX4504766 | human NET-CAGE GM12878, biol_rep1 | 250.2 |
| SRX4504741 | human NET-CAGE MCF-7, response to HRG, 60 min, biol_rep2 | 248.9 |
| SRX4504745 | human NET-CAGE MCF-7, response to HRG, 0 min, biol_rep3 | 247.2 |
| SRX4504753 | human NET-CAGE MCF-7, response to HRG, 120 min, biol_rep4 | 246.4 |
| SRX4504746 | human NET-CAGE MCF-7, response to HRG, 15 min, biol_rep3 | 236.5 |
| SRX4504763 | human CAGE GM12878, biol_rep2 | 233.2 |
| SRX4504743 | human NET-CAGE MCF-7, response to HRG, 180 min, biol_rep2 | 226.6 |
| SRX4504748 | human NET-CAGE MCF-7, response to HRG, 45 min, biol_rep3 | 225.6 |
| SRX4504749 | human NET-CAGE MCF-7, response to HRG, 60 min, biol_rep3 | 222.3 |
| CNhs11858 | mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162 | 221.7 |
| SRX4504751 | human NET-CAGE MCF-7, response to HRG, 180 min, biol_rep3 | 218.5 |
| SRX4504730 | human NET-CAGE MCF-7, response to HRG, 0 min, biol_rep1 | 216.9 |
| SRX4504724 | human CAGE MCF-7, response to HRG, 45 min, biol_rep3 | 215.1 |
| SRX4504762 | human CAGE GM12878, biol_rep1 | 215.0 |
| CNhs11834 | carcinoid cell line:NCI-H1770 | 212.7 |
| CNhs11891 | hereditary spherocytic anemia cell line:WIL2-NS | 210.7 |
| SRX4504747 | human NET-CAGE MCF-7, response to HRG, 30 min, biol_rep3 | 209.8 |
| SRX4504742 | human NET-CAGE MCF-7, response to HRG, 120 min, biol_rep2 | 209.5 |
| SRX4504732 | human NET-CAGE MCF-7, response to HRG, 30 min, biol_rep1 | 204.3 |
| SRX18306666 | TDP2 null mutant, empty vector overexpression_ treated with Estrogen_0.5h, rep1 | 203.7 |
| SRX4504731 | human NET-CAGE MCF-7, response to HRG, 15 min, biol_rep1 | 203.5 |
| SRX6586366 | CNhi10369_MCF-7_siRNA-negative control-48h_rep2 | 203.1 |
| CNhs14073 | occipital cortex, newborn, donor10223 | 202.6 |
| CNhs14406 | 293SLAM rinderpest infection, 00hr, biol_rep1 | 200.3 |
| SRX4504736 | human NET-CAGE MCF-7, response to HRG, 360 min, biol_rep2 | 198.9 |
| SRX18306669 | TDP2 null mutant, empty vector overexpression_ treated with Estrogen_0h, rep1 | 195.9 |
| SRX4504738 | human NET-CAGE MCF-7, response to HRG, 15 min, biol_rep2 | 194.4 |
| SRX18306663 | TDP2 null mutant, Intact TDP2 overexpression_treated with Estrogen_6h, rep3 | 193.0 |
| CNhs14074 | parietal lobe, newborn, donor10223 | 192.8 |
| SRX4504729 | human CAGE MCF-7, response to HRG, 120 min, biol_rep4 | 192.5 |
| SRX4504737 | human NET-CAGE MCF-7, response to HRG, 0 min, biol_rep2 | 192.3 |
| CNhs14245 | lung adenocarcinoma, papillary cell line:NCI-H441 | 190.3 |
| SRX6586264 | CNhi10334.AC_THP-1_siRNA-negative control-48h_rep5 | 190.1 |
| SRX4504727 | human CAGE MCF-7, response to HRG, 180 min, biol_rep3 | 189.7 |
| SRX18306665 | TDP2 null mutant, catalytic-dead TDP2 overexpression_treated with Estrogen_1 h, rep1 | 188.6 |
| SRX4504752 | human NET-CAGE MCF-7, response to HRG, 360 min, biol_rep3 | 187.4 |
| SRX4504725 | human CAGE MCF-7, response to HRG, 60 min, biol_rep3 | 186.7 |
| SRX6586367 | CNhi10369_MCF-7_siRNA-negative control-48h_rep3 | 183.2 |
| SRX18306667 | TDP2 null mutant, empty vector overexpression_ treated with Estrogen_0.5h, rep2 | 182.2 |
| SRX4504769 | human NET-CAGE GM12878, biol_rep2 | 182.1 |
| SRX4504726 | human CAGE MCF-7, response to HRG, 120 min, biol_rep3 | 181.3 |
| SRX6586263 | CNhi10333.AI_THP-1_siRNA (HSS179267) treatment-48h_rep2 | 178.9 |
| SRX4504735 | human NET-CAGE MCF-7, response to HRG, 180 min, biol_rep2 | 178.7 |
| SRX18306664 | TDP2 null mutant, catalytic-dead TDP2 overexpression_treated with Estrogen_0h, rep1 | 178.7 |
| SRX4504733 | human NET-CAGE MCF-7, response to HRG, 45 min, biol_rep1 | 175.2 |
| SRX4504739 | human NET-CAGE MCF-7, response to HRG, 30 min, biol_rep2 | 171.1 |
| SRX4504740 | human NET-CAGE MCF-7, response to HRG, 45 min, biol_rep2 | 170.2 |
| SRX6586289 | CNhi10324_HepG2_Atrovastatin-30 uM-48h_rep2 | 169.5 |
| CNhs11965 | Myoblast, donor2 | 168.9 |